EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis

Hiroki Inoue iD, Taku Kanda iD, Gakuto Hayashi iD, Ryota Munenaga iD, Masayuki Yoshida iD, Kana Hasegawa iD, Takuya Miyagawa iD, Yukiya Kurumada iD, Jumpei Hasegawa iD, Tomoyuki Wada iD, Motoi Horiuchi iD, Yasuhiro Yoshimatsu iD und 8 weitere

Journal of Cell Biology · 2024

DOI: 10.1083/jcb.202303102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Hiroki Inoue und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan. Hauptthemen laut MEDLINE: Cortactin, Microtubule-Associated Proteins, Triple Negative Breast Neoplasms, Adaptor Proteins, Vesicular Transport. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science, and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microtubule-associated protein MAP1B has been implicated in axonal growth and brain development. We found that MAP1B is highly expressed in the most aggressive and deadliest breast cancer subtype, triple-negative breast cancer (TNBC), but not in other subtypes. Expression of MAP1B was found to be highly correlated with poor prognosis. Depletion of MAP1B in TNBC cells impairs cell migration and invasion concomitant with a defect in tumorigenesis. We found that MAP1B interacts with key components for invadopodia formation, cortactin, and Tks5, the latter of which is a PtdIns(3,4)P2-binding and scaffold protein that localizes to invadopodia. We also found that Tks5 associates with microtubules and supports the association between MAP1B and α-tubulin. In accordance with their interaction, depletion of MAP1B leads to Tks5 destabilization, leading to its degradation via the autophagic pathway. Collectively, these findings suggest that MAP1B is a convergence point of the cytoskeleton to promote malignancy in TNBC and thereby a potential diagnostic and therapeutic target for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CortactinMicrotubule-Associated ProteinsTriple Negative Breast NeoplasmsAdaptor Proteins, Vesicular TransportHumansCarcinogenesisCell Transformation, NeoplasticMDA-MB-231 CellsMicrotubulesCytoskeletonFemaleAnimalsMiceMice, Inbred BALB CPodosomesTubulin

Substanzen

CortactinMAP1B protein, humanMicrotubule-Associated ProteinsSH3PXD2A protein, humanAdaptor Proteins, Vesicular TransportTubulin

Autor:innen und Institutionen

  • School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.
  • Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Cellular Physiological Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Department of Laboratory Medicine, National Cancer Center Hospital,Tokyo, Japan.
  • Department of Laboratory Medicine, School of Medicine, Keio University, Tokyo, Japan.

ORCID-Profile: Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, Kana Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, Motoi Horiuchi, Yasuhiro Yoshimatsu, Fumiko Itoh, Yuki Maemoto, Kohei Arasaki, Yuichi Wakana, Tetsuro Watabe, Hiromichi Matsushita, Hironori Harada, Mitsuo Tagaya

Förderung

  • Grants-in-Aid for Scientific Research
  • Ministry of Education, Culture, Sports, Science, and Technology

Zitieren

APA

Inoue, H., Kanda, T., Hayashi, G., Munenaga, R., Yoshida, M., Hasegawa, K., Miyagawa, T., Kurumada, Y., Hasegawa, J., Wada, T., Horiuchi, M., Yoshimatsu, Y., Itoh, F., Maemoto, Y., Arasaki, K., Wakana, Y., Watabe, T., Matsushita, H., Harada, H., & Tagaya, M. (2024). A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis. Journal of Cell Biology. https://doi.org/10.1083/jcb.202303102

Vancouver

Inoue H, Kanda T, Hayashi G, Munenaga R, Yoshida M, Hasegawa K, et al. A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis. Journal of Cell Biology. 2024. doi:10.1083/jcb.202303102

BibTeX
@article{Inoue2024,
  author = {Inoue, Hiroki and Kanda, Taku and Hayashi, Gakuto and Munenaga, Ryota and Yoshida, Masayuki and Hasegawa, Kana and Miyagawa, Takuya and Kurumada, Yukiya and Hasegawa, Jumpei and Wada, Tomoyuki and Horiuchi, Motoi and Yoshimatsu, Yasuhiro and Itoh, Fumiko and Maemoto, Yuki and Arasaki, Kohei and Wakana, Yuichi and Watabe, Tetsuro and Matsushita, Hiromichi and Harada, Hironori and Tagaya, Mitsuo},
  title = {A MAP1B–cortactin–Tks5 axis regulates TNBC invasion and tumorigenesis},
  journal = {Journal of Cell Biology},
  year = {2024},
  doi = {10.1083/jcb.202303102}
}
Kostenlos starten →